CD4 and tuberculosis: Among people with CD4 count ≥50 cells/μL (n = 2,241), a successful TB outcome was less likely when ART was initiated after 16–56 days rather than within 2 weeks after commencing TB therapy (aRR 0.96 [0.93–0.99], p = 0.016), with fewer people being cured (22.4% vs 25.9%, see Supplementary Table S3) and more people failing treatment (0.8% vs 0.4%), LTFU (10.6% vs 8.5%) and dying (2.6% vs 1.6%).